ArticleClinical epigenetics2019

Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.

Masayo Kagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.